BioSpace News Archive

Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that the Wellcome Sanger Institute has committed to purchase seven new Sequel IIe Systems and upgrade its five existing Sequel II Systems to increase its long-read sequencing capabilities for projects including the Darwin Tree of Life (DToL; all eukaryotes in Britain and Ireland) and Aquatic Symbiosis G

Citrine Medicine, a China-based rare disease therapeutics company, today announced that company management will participate at three conferences in January, including the 39th Annual J.P. Morgan Healthcare Conference.

ATP, a leading life sciences venture capital firm, and Biolojic Design, a biotechnology company that computationally designs functional antibodies, today unveiled Aulos Bioscience, a new company that is developing highly differentiated interleukin-2 (IL-2)-binding monoclonal antibodies as therapeutics against solid tumors

Demand for dental restoratives is on askyward rise as a huge proportion of the worldwide population is focusing on oral health, the incidences of dental decay are rapidlyfalling.

Transparency Market Research in a new market study reports that the global vitreous tamponades market is highly fragmented with the presence of small and medium sized players.

Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies to address major industry challenges and fulfill unmet medical needs in the treatment of cancer, announced the pricing of its initial public offering of 11,000,000 American Depositary Shares, each representing five ordinary shares, at a public offering price of US$19.00 per ADS.

Lead pneumococcal vaccine in clinical development offers potential for broader protection than any vaccine on the market or in clinical trials today

Pivotal Data Anticipated in 2021 to Support Potential Registration, Addressing an Estimated Market Opportunity of Greater than $500 Million

Greenwich LifeSciences, Inc. announced that Snehal Patel, CEO of Greenwich LifeSciences, will participate in three virtual investor conferences during the week of January 11, 2021.

OTTAWA, ON , Jan. 8, 2021 /CNW/ - Note: All times local Ottawa, Ontario Private meetings. 11 :30 a.m. The Prime Minister will address Canadians on the COVID-19 situation. A media availability will follow. Rideau Cottage 1 Sussex Drive Notes for media: